Financials
- Market Capitalization 1.91 B
- Employee 59
- Founded 2019
- CEO N/A
- Website www.sionnatx.com
- Headquarter Delaware, United States
- FIGI BBG016X2DC85
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-21.55
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2013 | AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | 17.46 USD | -4.07% | +0.11% | +14.87% | +114.50% | 1.94 B USD | ||
| 2016 | NBTX Nanobiotix S.A. - ADSs | 40.52 USD | -2.69% | +5.82% | +14.46% | +668.88% | 1.96 B USD | ||
| 2032 | TYRA Tyra Biosciences, Inc. - Common Stock | 31.93 USD | -2.89% | +0.79% | +11.84% | +122.66% | 1.90 B USD | ||
| 2034 | SRPT Sarepta Therapeutics, Inc. - Common Stock | 17.25 USD | -3.95% | -13.10% | +9.38% | -5.74% | 1.82 B USD |